A Phase II trial of bryostatin-1 for patients with metastatic renal cell carcinoma - Concepedia

Concepedia

Publication | Closed Access

A Phase II trial of bryostatin-1 for patients with metastatic renal cell carcinoma

50

Citations

9

References

2000

Year

Lance C. Pagliaro, Danai Daliani, Robert J. Amato, Shi‐Ming Tu, Donnah Jones, Terry J. Smith, Christopher J. Logothetis, Randall E. Millikan

Abstract

There is minimal, if any, clinically relevant single-agent activity of bryostatin-1 at this dose and schedule for patients with metastatic renal cell carcinoma.

References

	Year	Citations

Page 1